References
- Wang DS, Pan CC, Lai HC, Huang JM. Expression of HMGA1 and Ezrin in laryngeal squamous cell carcinoma. Acta Otolaryngol 2013;133:626–32.
- Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005;5:615–25.
- van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643–7.
- Meek DW, Marcar L. MAGE-A antigens as targets in tumour therapy. Cancer Lett 2012;324:126–32.
- Sang M, Lian Y, Zhou XL, Shan B. MAGE-A family: Attractive targets for cancer immunotherapy. Vaccine 2011;29:8496–500.
- Sang M, Wang L, Ding C, Zhou X, Wang L, Lian Y, et al. Melanoma-associated antigen genes - an update. . Cancer Lett 2011;302:85–90.
- De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994;40:360–9.
- Gu X, Fu M, Ge Z, Zhan F, Ding Y, Ni H, et al. High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma. Sci Rep 2014;4:Article number 6625. DOI: 10.1038/srep06625.
- Zhang S, Zhai X, Wang G, Feng J, Zhu H, Xu L, et al. High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival. Int J Clin Exp Pathol 2015;8:541–50.
- Hatiboglu G, Pritsch M, Macher-Goeppinger S, Zoller M, Huber J, Haferkamp A, et al. Prognostic value of melanoma-associated antigen A9 in renal cell carcinoma. Scand J Urol 2013;47:311–22.
- Xu Y, Wang C, Zhang Y, Jia L, Huang J. Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer. Sci Rep 2015;5:12104
- Shantha KH, Grieco MJ, Caballero OL, Su T, Ahmed A, Ritter E, et al. MAGE-A3 is highly expressed in a subset of colorectal cancer patients. Cancer Immun 2012;12:16
- Lee TB, Lim SC, Moon YS, Choi CH. Melanoma antigen gene family A as a molecular marker of gastric and colorectal cancers. Oncol Rep 2013;30:234–8.
- Hudolin T, Kastelan Z, Ilic I, Levarda-Hudolin K, Basic-Jukic N, Rieken M, et al. Immunohistochemical analysis of the expression of MAGE-A and NY-ESO-1 cancer/testis antigens in diffuse large B-cell testicular lymphoma. J Transl Med 2013;11:123. DOI: 10.1186/1479-5876-11-123.
- Laban S, Atanackovic D, Luetkens T, Knecht R, Busch CJ, Freytag M, et al. Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer. Int J Cancer 2014;135: 1142–52.
- Cuffel C, Rivals JP, Zaugg Y, Salvi S, Seelentag W. Speiser, et al. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma. Int J Cancer 2011;28:2625–34.
- Hartmann S, Kriegebaum U, Küchler N, Brands RC, Linz C, Kübler AC, et al. Correlation of MAGE-A tumor antigens and the efficacy of various chemotherapeutic agents in head and neck carcinoma cells. Clin Oral Investig 2014;18:189–97.
- Han L, Jiang B, Wu H, Zhang S, Lu X. Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma. Int J Clin Exp Pathol 2014;7:6734–42.
- Lian Y, Sang M, Ding C, Zhou X, Fan X, Xu Y, et al. Expressions of MAGE-A10 and MAGE-A11 in breast cancers and their prognostic significance: a retrospective clinical study. J Cancer Res Clin Oncol 2012;138:519–27.
- Guo L, Sang M, Liu Q, Fan X, Zhang X, Shan B. The expression and clinical significance of melanoma-associated antigen-A1, -A3 and -A11 in glioma. Oncol Lett 2013;6:55–62.